Sorin Group Announces the Appointment of Fred Hrkac as President Cardiac Rhythm Management Business Unit

The Sorin Group (MIL:SRN) announced today that Fred Hrkac has been
appointed President, Cardiac Rhythm Management (CRM) Business Unit,
reporting to Andre-Michel Ballester, recently appointed CEO of the
Sorin Group, the largest European cardiovascular company and world
leader in medical technologies for cardiac surgery.

Since 2005, Fred Hrkac has been Vice President, Global Sales and
Marketing, of the Sorin Group CRM Business Unit.

Fred Hrkac, a Canadian/ Croatian national brings with him thorough
international management experience in Sales and Marketing.

He spent most of his career within Johnson and Johnson in various
positions in Sales and Marketing. In his last position, he was Vice
President Worldwide Sales & Marketing for Biosense Webster, a global
leader in Electrophysiology.

He has good knowledge of Europe where he has been working for 15
years living in five different countries, as well as in the USA and
Canada.

He was raised in Canada and graduated from Wilfrid Laurier
University, Waterloo, Ontario (Canada) with a Honors Bachelor Business
Administration degree.

"I am very proud and honoured to become President of this Business
Unit, an emerging player in the CRM industry. In my new role I will
continue to make it possible for Sorin Group to expand its
presence worldwide thanks to our talented employees and innovative
solutions that we bring to patients and physicians worldwide."

About the Sorin Group

The Sorin Group (Bloomberg: SRN.IM; Reuters: SORN.MI), a world
leader in the development of medical technologies for cardiac surgery,
offers innovative therapies for cardiac rhythm dysfunctions,
interventional cardiology and the treatment of chronic kidney
diseases. The Sorin Group includes these brands: Dideco, CarboMedics,
COBE Cardiovascular, Stockert, Mitroflow, ELA Medical, Sorin
Biomedica, Bellco and Bellco-Soludia. At the Sorin Group 4,500
employees work to serve over 5,000 public and private treatment
centers in more than 80 countries throughout the world. For more
information, please visit: www.sorin.com